HKSE - Delayed Quote HKD

SIHUAN PHARM (0460.HK)

0.670
+0.010
+(1.52%)
At close: 4:08:18 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,901,109
1,901,109
1,860,539
2,181,189
3,038,391
Cost of Revenue
659,399
659,399
564,895
693,608
607,903
Gross Profit
1,241,710
1,241,710
1,295,644
1,487,581
2,430,488
Operating Expense
1,703,605
1,703,605
1,487,129
2,041,789
1,782,809
Operating Income
-461,895
-461,895
-191,485
-554,208
647,679
Net Non Operating Interest Income Expense
-99,383
-99,383
-121,429
-64,382
46,597
Pretax Income
-428,288
-428,288
-161,260
-2,122,778
496,013
Tax Provision
43,261
43,261
96,427
196,794
253,119
Net Income Common Stockholders
-216,662
-216,662
-54,017
-1,914,918
416,509
Diluted NI Available to Com Stockholders
-216,662
-216,662
-54,017
-1,914,918
416,509
Basic EPS
-0.02
--
-0.01
-0.21
0.04
Diluted EPS
-0.02
--
-0.01
-0.21
0.04
Basic Average Shares
9,265,984
--
9,297,073
9,329,999
9,431,297
Diluted Average Shares
9,265,984
--
9,297,073
9,336,768
9,487,676.538
Total Operating Income as Reported
-138,131
-138,131
161,698
-1,830,727
771,945
Total Expenses
2,363,004
2,363,004
2,052,024
2,735,397
2,390,712
Net Income from Continuing & Discontinued Operation
-216,662
-216,662
-54,017
-1,914,918
416,509
Normalized Income
-256,532
-256,532
-174,833.750
-883,906.250
474,354.750
Interest Income
175,548
175,548
147,908
146,794
163,948
Interest Expense
274,931
274,931
269,337
211,176
117,351
Net Interest Income
-99,383
-99,383
-121,429
-64,382
46,597
EBIT
-153,357
-153,357
108,077
-1,911,602
613,364
EBITDA
105,069
105,069
334,310
-1,541,795
922,731
Reconciled Cost of Revenue
659,399
659,399
564,895
693,608
607,903
Reconciled Depreciation
258,426
258,426
226,233
369,807
309,367
Net Income from Continuing Operation Net Minority Interest
-216,662
-216,662
-54,017
-1,951,214
426,633
Total Unusual Items Excluding Goodwill
53,160
53,160
161,089
-1,423,077
-63,629
Total Unusual Items
53,160
53,160
161,089
-1,423,077
-63,629
Normalized EBITDA
51,909
51,909
173,221
-118,718
986,360
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
13,290
13,290
40,272.250
-355,769.250
-15,907.250
12/31/2021 - 10/28/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

600518.SS Kangmei Pharmaceutical Co., Ltd.
1.9700
+0.51%
 
0719.HK SHANDONG XINHUA
6.210
+8.95%
 
0013.HK HUTCHMED
21.200
+1.92%
 
0950.HK LEE'S PHARM
1.390
+3.73%
 
2552.HK Hua Medicine (Shanghai) Ltd.
2.090
+1.46%
 
2877.HK China Shineway Pharmaceutical Group Limited
7.150
+0.85%
 
0570.HK TRAD CHI MED
2.130
-0.93%
 
6896.HK Golden Throat Holdings Group Company Limited
5.430
+6.26%
 
2196.HK Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
14.000
+1.01%
 
0867.HK CMS
8.240
+0.73%